CID 102039240

[(2s,3s,4s,5r,6r)-2-[(2r,3s,4s,5s,6s)-2-[(2r)-2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidin-4-yl]amino]-3-[[5-[[1-[2-[4-[4-[3-[4-[(3-amino-3-oxopropyl)amino]butylamino]propylcarbamoyl]-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]ethylamino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-hydroxy-4-methyl-5-oxopentan-2-yl]amino]-1-(1h-imidazol-5-yl)-3-oxopropoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] carbamate

Structural Information

Molecular Formula
C59H94N20O21S2
SMILES
CC1=C(N=C(N=C1N[C@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCCNCCCCNCCC(=O)N)O)C(CC(=O)N)NCC(C(=O)N)N)N
InChI
InChI=1S/C59H94N20O21S2/c1-24(52(91)77-38(27(4)82)54(93)70-15-9-37-74-32(22-101-37)56-75-31(21-102-56)53(92)69-13-7-12-66-10-5-6-11-67-14-8-35(61)83)40(85)26(3)73-55(94)39(76-50-25(2)48(63)78-51(79-50)29(16-36(62)84)71-17-28(60)49(64)90)45(30-18-68-23-72-30)98-58-47(43(88)41(86)33(19-80)97-58)99-57-44(89)46(100-59(65)95)42(87)34(20-81)96-57/h18,21-24,26-29,33-34,38-47,57-58,66-67,71,80-82,85-89H,5-17,19-20,60H2,1-4H3,(H2,61,83)(H2,62,84)(H2,64,90)(H2,65,95)(H,68,72)(H,69,92)(H,70,93)(H,73,94)(H,77,91)(H3,63,76,78,79)/t24?,26?,27?,28?,29?,33-,34+,38?,39+,40?,41+,42+,43-,44-,45?,46-,47-,57-,58-/m0/s1
InChIKey
KARUSHFAXMKMET-FOGSEAEJSA-N
Compound name
[(2S,3S,4S,5R,6R)-2-[(2R,3S,4S,5S,6S)-2-[(2R)-2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidin-4-yl]amino]-3-[[5-[[1-[2-[4-[4-[3-[4-[(3-amino-3-oxopropyl)amino]butylamino]propylcarbamoyl]-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]ethylamino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-hydroxy-4-methyl-5-oxopentan-2-yl]amino]-1-(1H-imidazol-5-yl)-3-oxopropoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] carbamate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

1482.6344 Da
Monoisotopic Mass

-8.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 1483.6417 394.1
[M+Na]+ 1505.6236 387.0
[M-H]- 1481.6271 397.5
[M+NH4]+ 1500.6682 392.3
[M+K]+ 1521.5976 393.5
[M+H-H2O]+ 1465.6317 370.9
[M+HCOO]- 1527.6326 388.5
[M+CH3COO]- 1541.6483 387.2
[M+Na-2H]- 1503.6091 422.7
[M]+ 1482.6339 404.9
[M]- 1482.6349 404.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.